The news that the Canadian pharmaceutical company Easton Pharmaceuticals Inc., listed on the Nasdaq, has signed a letter of intent to acquire an interest in or participate in the development of a casino-hotel resort in Europe has aroused great curiosity. The project will consist of 538…

To read this article

Log in or register

Previous articleHolland fears the mixing of gaming and gambling
next articleThe Sisal Art Place reopens the doors of 'Tasting Art' the cycle of talks dedicated to Italian Contemporary Art